Literature DB >> 27131022

Mammary Analogue Secretory Carcinoma (MASC) of the salivary gland: A new tumor entity.

Ivan Damjanov1, Faruk Skenderi, Semir Vranic.   

Abstract

Mammary analogue secretory carcinoma (MASC) is a recently described low-grade malignant tumor of the salivary glands, biologically and morphologically equivalent to secretory breast carcinoma. We give a brief overview of this new entity, including morphological, immunohistochemical, molecular-genetic, clinical, epidemiologic features, differential diagnosis, and outcome results.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27131022      PMCID： PMC4978118          DOI： 10.17305/bjbms.2016.1321

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN： 1512-8601            Impact factor:   3.363


  10 in total

1.  Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.

Authors:  Yohei Ito; Kenichiro Ishibashi; Ayako Masaki; Kana Fujii; Yukio Fujiyoshi; Hideo Hattori; Daisuke Kawakita; Manabu Matsumoto; Satoru Miyabe; Kazuo Shimozato; Toshitaka Nagao; Hiroshi Inagaki
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

2.  Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics.

Authors:  Peter P Luk; Christina I Selinger; Timothy J Eviston; Trina Lum; Bing Yu; Sandra A O'Toole; Jonathan R Clark; Ruta Gupta
Journal:  Pathology       Date:  2015-12       Impact factor: 5.306

3.  Mammary analogue secretory carcinoma of parotid: Is preoperative cytological diagnosis possible?

Authors:  Nikita Oza; Kintan Sanghvi; Tanuja Shet; Asawari Patil; Santosh Menon; Mukta Ramadwar; Shubhada Kane
Journal:  Diagn Cytopathol       Date:  2016-03-04       Impact factor: 1.582

4.  Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.

Authors:  Makoto Urano; Toshitaka Nagao; Satoru Miyabe; Kenichiro Ishibashi; Kayoko Higuchi; Makoto Kuroda
Journal:  Hum Pathol       Date:  2014-10-07       Impact factor: 3.466

5.  Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Authors:  Alena Skálová; Tomas Vanecek; Radek Sima; Jan Laco; Ilan Weinreb; Bayardo Perez-Ordonez; Ivo Starek; Marie Geierova; Roderrick H W Simpson; Fabricio Passador-Santos; Ales Ryska; Ilmo Leivo; Zdenek Kinkor; Michal Michal
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

6.  Aspiration cytology of mammary analogue secretory carcinoma of the salivary gland.

Authors:  Min Jung Jung; Sang Yoon Kim; Soon Yuhl Nam; Jong-Lyel Roh; Seung-Ho Choi; Jeong Hyun Lee; Jung Hwan Baek; Kyung-Ja Cho
Journal:  Diagn Cytopathol       Date:  2014-08-04       Impact factor: 1.582

7.  Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.

Authors:  Alena Skálová; Tomas Vanecek; Hanna Majewska; Jan Laco; Petr Grossmann; Roderick H W Simpson; Lukas Hauer; Pavel Andrle; Lubor Hosticka; Jindrich Branžovský; Michal Michal
Journal:  Am J Surg Pathol       Date:  2014-01       Impact factor: 6.394

8.  Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.

Authors:  Alena Skálová; Tomas Vanecek; Roderick H W Simpson; Jan Laco; Hanna Majewska; Martina Baneckova; Petr Steiner; Michal Michal
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

9.  Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.

Authors:  Hanna Majewska; Alena Skálová; Dominik Stodulski; Adéla Klimková; Petr Steiner; Czesław Stankiewicz; Wojciech Biernat
Journal:  Virchows Arch       Date:  2014-12-12       Impact factor: 4.064

10.  What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).

Authors:  A Drilon; G Li; S Dogan; M Gounder; R Shen; M Arcila; L Wang; D M Hyman; J Hechtman; G Wei; N R Cam; J Christiansen; D Luo; E C Maneval; T Bauer; M Patel; S V Liu; S H I Ou; A Farago; A Shaw; R F Shoemaker; J Lim; Z Hornby; P Multani; M Ladanyi; M Berger; N Katabi; R Ghossein; A L Ho
Journal:  Ann Oncol       Date:  2016-02-15       Impact factor: 32.976
  10 in total
  3 in total

1.  Synchronous Parotid (Mammary Analog) Secretory Carcinoma and Acinic Cell Carcinoma: Report of a Case.

Authors:  C Mossinelli; C Pigni; F Sovardi; A Occhini; L Preda; M Benazzo; P Morbini; F Pagella
Journal:  Head Neck Pathol       Date:  2018-06-06

2.  A case report of parotid mammary analogue secretory carcinoma and reviews.

Authors:  Luona Sun; Teagan Thorson; Roger Zhu; Jerry Huo; Jiankun Tong; William H Rodgers; Larry Shemen
Journal:  Int J Surg Case Rep       Date:  2019-01-19

3.  Parotid mammary analogue secretory carcinoma: A case report and review of literature.

Authors:  Feng-He Min; Jia Li; Bo-Qiang Tao; Hui-Min Liu; Zhi-Jing Yang; Lu Chang; Yu-Yang Li; Ying-Kun Liu; Yi-Wen Qin; Wei-Wei Liu
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.